文献速递炎症性肠病肝病

炎症性肠病患者中原发性硬化性胆管炎的患病率:系统评价与荟萃分析

Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
PubMed 文献 · Gastroenterology · 2021-08-20

该研究通过系统评价和荟萃分析,纳入64项观察性研究、共776,700例成人IBD患者,评估PSC的患病率。结果显示IBD患者中PSC总体合并患病率为2.16%,UC患者(2.47%)显著高于CD患者(0.96%),OR为1.69(95%CI 1.24-2.29),且患病率受性别、病变范围及地理区域影响。

要点

  • IBD患者中PSC总体合并患病率为2.16%。
  • UC患者PSC患病率显著高于CD患者(OR 1.69)。
  • 男性及病变范围更广者PSC患病率更高。

核心结论

  • IBD患者中PSC的总体合并患病率为2.16%,UC高于CD,且受性别、病变范围及地理区域影响。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase和Embase Classic(自建库至2021年4月10日),纳入64项观察性研究,共776,700例成人IBD患者。

主要发现

  • PSC在IBD中的总体合并患病率为2.16%,南美洲最高,东南亚最低。
  • UC、CD及IBD-unclassified患者的合并患病率分别为2.47%、0.96%和5.01%。
  • UC患者PSC患病率显著高于CD患者(OR 1.69,95%CI 1.24-2.29)。
  • 采用肝生化联合ERCP/MRCP定义PSC的研究合并患病率最高(2.88%),临床诊断者最低(1.79%)。
  • 男性、UC病变范围更广(广泛性 vs 左侧)、CD病变范围更广(回结肠/结肠 vs 回肠)者患病率更高。

临床怎么用

  • 对IBD患者应警惕PSC可能,尤其UC、男性及病变范围广泛者,以便及时诊断并启动相关消化道恶性肿瘤监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Although the association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) is well recognized, uncertainties remain about the magnitude of this problem. We conducted a systematic review and meta-analysis assessing prevalence of PSC in IBD to investigate whether type of IBD, how presence of PSC was defined, sex, disease extent or location, time period, or geographic location influenced prevalence. METHODS: Medline, Embase, and Embase Classic were searched (from inception to April 10, 2021) to identify observational studies recruiting ≥50 adult patients with IBD and reporting prevalence of PSC. Data were extracted, and pooled prevalence, odds ratios (ORs), and 95% confidence intervals (CIs) calculated. RESULTS: Of 1204 citations, 64 studies were eligible, containing 776,700 patients. Overall, pooled prevalence of PSC in IBD was 2.16%; it was highest in South America and lowest in Southeast Asia. Pooled prevalences in patients with ulcerative colitis (UC), Crohn's disease (CD), and IBD-unclassified were 2.47%, 0.96%, and 5.01%, respectively. Pooled prevalence was significantly higher in UC versus CD (OR 1.69, 95% CI 1.24-2.29). In subgroup analyses according to method used to define presence of PSC, the highest prevalence was 2.88% in studies performing both liver biochemistry and endoscopic retrograde/magnetic resonance cholangiopancreatography and the lowest was 1.79% in studies using a clinical diagnosis. Prevalence was generally higher in men, patients with more extensive, compared with left-side, UC or ileocolonic or colonic, compared with ileal, CD. CONCLUSIONS: Our findings provide the first pooled estimates of the burden of PSC in IBD, as well as potential risk factors, which may be important in establishing a prompt diagnosis and initiating appropriate surveillance for relevant gastrointestinal malignancies.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Barberio B, Massimi D, Cazzagon N, et al. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology. 2021. PMID: 34425093. doi:10.1053/j.gastro.2021.08.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。